Neuron-specific Hel-N1 and HuD as novel molecular markers of neuroblastoma: A correlation of HuD messenger RNA levels with favorable prognostic features

Clinical Cancer Research

Volumn 3, Issue 10, 1997, Pages 1859-1865

  Ball, N Sharie ^a   King, Peter H ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UAB Department of Neurology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE ISOLATION; HUMAN; HUMAN CELL; MALE; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTIGENE FAMILY; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; RNA-BINDING PROTEINS; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030825633     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kim, Y. S., and Baker, B. S. The Drosophila gene rbp9 encodes a protein that is a member of a conserved group of putative RNA binding proteins that are nervous system-specific in both flies and humans. J. Neurosci., 13: 1045-1056, 1993.
2. Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J. B., and Furneaux, H. M. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA binding domains and is homologous to elav and sex-lethal. Cell, 67: 325-333, 1991.
3. King, P. H., Levine, T. D., Fremeau, R. T., and Keene, J. D. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′UTR of mRNA encoding the Id transcriptional repressor. J. Neurosci., 14: 1943-1952, 1994.
4. Kenan, D. J., Query, C. C., and Keene, J. D. RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci., 16: 214-220, 1991.
5. Dreyfuss, G., Swanson, M. S., and Pinol-Roma, S. Heterogeneous nuclear ribonucleoprotein particles and the pathway of mRNA. Trends Biochem. Sci., 13: 86-91, 1988.
6. Robinow, S., Campos, A., Yao, K., and White, K. The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science (Washington DC), 242: 1570-1572, 1988.
7. Yao, K., Samson, M., Reeves, R., and White, K. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J. Neurobiol., 24: 723-739, 1993.
8. King, P. H. Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis. Gene (Amst.), 151: 261-265, 1994.
9. King, P. H., and Dropcho, E. J. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma. Ann. Neurol., 39: 679-681, 1996.
10. Manley, G. T., Smitt, P. S., Dalmau, J., and Posner, J. B. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol., 38: 102-110, 1995.
11. King, P. H. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype. Int. J. Cancer, in press, 1997.
12. Gazdar, A. F., Carney, D. N., Nau, M. M., and Minna, J. D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res., 45: 2924-2930, 1985.
13. Carney, D. N., Mitchell, J. B., and Kinsella, T. J. In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res., 43: 2806-2811, 1983.
14. Gazdar, A. F., Carney, D. N., Guccion, J. G., and Baylin, S. B. In: F. A. Greco, R. K. Oldham, and P. A. Bunn (eds.), Small Cell Lung Cancer, pp. 145-175. New York: Grune & Stratton, 1981.
15. Dalmau, J., Furneaux, H. M., Cordon-Cardo, C., and Posner, J. B. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol., 141: 881-886, 1992.
16. Dalmau, J., Graus, F., Cheung, N. V., Rosenblum, M. K., Ho, A., Canete, A., Delattre, J., Thompson, S. J., and Posner, J. B. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (Phila.), 75: 99-108, 1995.
17. Marusich, M. F., Furneaux, H. M., Henion, P. D., and Weston, J. A. Hu neuronal proteins are expressed in proliferating neurogenic cells. J. Neurobiol., 25: 143-155, 1994.
18. Cohn, S. L., Salwen, H., Quasney, M. W., Ikegaki, N., Cowan, J. M., Herst, C. V., Kennett, R. H., Rosen, S. T., DiGiuseppe, J. A., and Brodeur, G. M. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene, 5: 1821-1827, 1990.
19. Seeger, R. C., Danon, Y. L., Rayner, S. A., and Hoover, F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J. Immunol., 128: 983-989, 1982.
20. Biedler, J. L., Helson, L., and Spengler, B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2642-2643, 1973.
21. Tumilowicz, J. J., Nichols, W. W., Cholon, J. J., and Greene, A. E. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res., 30: 2110-2118, 1970.
22. Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L. T., Castel, V., Castleberry, R. P., DeBernardi, B., Evans, A. E., Favrot, M., Hedborg, F., Kaneko, M., Kemshead, J. T., Lampert, F., Lee, R. E. J., Look, A. T., Pearson, A. D. J., Philip, T., Roald, B., Sawada, T., Seeger, R. C., Tsuchida, Y., and Vout, P. A. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993.
23. Shimada, H., Chatten, J., Newton, W. A., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastomas and an age-linked classification of neuroblastomas. J. Natl. Cancer Inst., 73: 405-416, 1984.
24. Nitschke, R., Smith, E. I., Shochat, S., Altshuler, G., Travers, H., Shuster, J. J., Hayes, F. A., Patterson, R., and McWilliams, N. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group study. J. Clin. Oncol., 6: 1271-1279, 1988.
25. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
26. Shapiro, D. N., Valentine, M. B., Rowe, S. T., Sinclair, A. E., Sublett, J. E., Roberts, W. M., and Look, A. T. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am. J. Pathol., 142: 1339-1346, 1993.
27. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
28. Dropcho, E. J., and King, P. H. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies. Ann. Neurol., 36: 200-205, 1994.
29. Sekido, Y., Bader, S. A., Carbone, D. P., Johnson, B. E., and Minna, J. D. Molecular analysis of the Hud gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res., 54: 4988-4992, 1994.
30. Liu, J., Dalmau, J., Szabo, A., Rosenfeld, M., Huber, J., and Furneaux, H. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology, 45: 544-550, 1995.
31. Robinow, S., and White, K. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev. Biol., 126: 294-303, 1988.
32. Graus, F., and Ferrer, I. Analysis of a neuronal antigen (Hu) expression in the developing rat brain detected by autoantibodies from patients with paraneoplastic encephalomyelitis. Neurosci. Lett., 112: 14-18, 1989.
33. Good, P. J. A conserved family of elav-like genes in vertebrates. Proc. Natl. Acad. Sci. USA, 92: 4557-4561, 1995.
34. Dalmau, J., Graus, F., Cheung, N. V., Rosenblum, M. K., Ho, A., Canete, A., Delattre, J., Thompson, S. J., and Posner, J. B. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (Phila.), 75: 99-109, 1995.
35. Dalmau, J., Graus, F., Rosenblum, M. K., and Posner, J. B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore), 71: 59-72, 1992.
36. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced stage disease. Science (Washington DC), 244: 1121-1124, 1984.
37. Radice, P., Matthews, M. J., Ihde, D. C., Gazdar, A. F., Carney, D. N., Bunn, P. A., Cohen, M. H., Fossieck, B. E., Makuch, R. W., and Minna, J. D. The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes. Cancer (Phila.), 50: 2894-2902, 1982.
38. Carney, D. N., Brower, M., Morstyn, G., Mitchell, J. B., and Kinsella, T. J. In: K. L. Becker and A. F. Gazdar (eds.), The Endocrine Lung in Health and Disease, pp. 603-611. Philadelphia: W. B. Saunders Company, 1984.
39. Johnson, B. E., Battey, J., Linnoila, I., Becker, K. L., Makuch, R. W., Snider, R. H., Carney, D. N., and Minna, J. D. Myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J. Clin. Invest., 78: 525-532, 1987.
40. de Leij, L., Postmus, P. E., Buys, C., Elema, J. D., Ramaekers, F., Poppema, S., Brouwer, M., van der Veen, A. Y., Mesander, G., and The, T. H. Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res., 45: 6024-6033, 1985.
41. Chung, S., Jiang, L., Cheng, S., and Furneaux, H. Purification and properties of HuD, a neuronal RNA-binding protein. J. Biol. Chem., 271: 11518-11524, 1996.
42. Shaw, G., and Kamen, R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46: 659-667, 1986.
43. Muresu, R., Baldini, A., Gress, T., Posner, J. B., Furneaux, H. M., and Siniscalco, M. Mapping of the gene coding for a paraneoplastic encephalomyelitis antigen (HuD) to human chromosome site 1p34. Cytogenet. Cell Genet., 65: 177-178, 1994.
44. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., and Brodeur, G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
45. Takita, J., Hayashi, Y., Kohno, T., Shiseki, M., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Allelotype of neuroblastoma. Oncogene, 11: 1829-1834, 1995.
46. Caron, H., van Sluis, P., de Kraker, J., Bokkerink, J., Egeler, M., Laureys, G., Slater, R., Westerveld, A., Voute, P. A., and Versteeg, R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 1608-1609, 1996.
47. Chagnovich, D., Fayos, B. E., and Cohn, S. L. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma. J. Biol. Chem., 271: 33587-33591, 1996.
48. Chagnovich, D., and Cohn, S. L. Binding of a 40-kDa protein to the N-myc 3′-untranslated region correlates with enhanced N-myc expression in human neuroblastoma. J. Biol. Chem., 271: 33580-33586, 1996.